Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Open-label Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease

NCT01267994 is registered in ClinicalTrials.gov with Andrea Vambutas as lead sponsor.

NCT NCT01267994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01267994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Open-label Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease
Lead sponsor
Andrea Vambutas
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2011
Completion date
September 30, 2014
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune inner ear disease, sensorineural hearing loss